Mesoblast cell treatment shows promise in rheumatoid arthritis : study
(Reuters) - Mesoblast Ltd on Monday said its experimental stem-cell treatment led to significant improvements of symptoms and disease activity in patients whose rheumatoid arthritis had stopped being helped by widely used biotech medicines, according to data from a mid-stage trial.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Arthritis | Biotechnology | Health | Rheumatoid Arthritis | Rheumatology | Stem Cell Therapy | Stem Cells | Study